77 related articles for article (PubMed ID: 10422789)
1. Dual intracellular signaling pathways mediated by the human cannabinoid CB1 receptor.
Calandra B; Portier M; Kernéis A; Delpech M; Carillon C; Le Fur G; Ferrara P; Shire D
Eur J Pharmacol; 1999 Jun; 374(3):445-55. PubMed ID: 10422789
[TBL] [Abstract][Full Text] [Related]
2. Agonist-dependent cannabinoid receptor signalling in human trabecular meshwork cells.
McIntosh BT; Hudson B; Yegorova S; Jollimore CA; Kelly ME
Br J Pharmacol; 2007 Dec; 152(7):1111-20. PubMed ID: 17922024
[TBL] [Abstract][Full Text] [Related]
3. Structural determinants of the partial agonist-inverse agonist properties of 6'-azidohex-2'-yne-delta8-tetrahydrocannabinol at cannabinoid receptors.
Ross RA; Gibson TM; Stevenson LA; Saha B; Crocker P; Razdan RK; Pertwee RG
Br J Pharmacol; 1999 Oct; 128(3):735-43. PubMed ID: 10516656
[TBL] [Abstract][Full Text] [Related]
4. O-1057, a potent water-soluble cannabinoid receptor agonist with antinociceptive properties.
Pertwee RG; Gibson TM; Stevenson LA; Ross RA; Banner WK; Saha B; Razdan RK; Martin BR
Br J Pharmacol; 2000 Apr; 129(8):1577-84. PubMed ID: 10780961
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid CB1-receptor mediated regulation of gastrointestinal motility in mice in a model of intestinal inflammation.
Izzo AA; Fezza F; Capasso R; Bisogno T; Pinto L; Iuvone T; Esposito G; Mascolo N; Di Marzo V; Capasso F
Br J Pharmacol; 2001 Oct; 134(3):563-70. PubMed ID: 11588110
[TBL] [Abstract][Full Text] [Related]
6. Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors.
Redmond WJ; Cawston EE; Grimsey NL; Stuart J; Edington AR; Glass M; Connor M
Br J Pharmacol; 2016 Jan; 173(1):115-27. PubMed ID: 26398720
[TBL] [Abstract][Full Text] [Related]
7. A quantitative pharmacology model for cannabinoid CB
Yang L; Finlay DB; Green HM; Zhu X; Glass M; Duffull S
Br J Pharmacol; 2024 Apr; 181(8):1324-1340. PubMed ID: 38072805
[TBL] [Abstract][Full Text] [Related]
8. Gα
Finlay DB; Cawston EE; Grimsey NL; Hunter MR; Korde A; Vemuri VK; Makriyannis A; Glass M
Br J Pharmacol; 2017 Aug; 174(15):2545-2562. PubMed ID: 28516479
[TBL] [Abstract][Full Text] [Related]
9. Signal transduction via cannabinoid receptors.
Dalton GD; Bass CE; Van Horn CG; Howlett AC
CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):422-31. PubMed ID: 19839935
[TBL] [Abstract][Full Text] [Related]
10. Fenofibrate Recognition and G
Wang T; Tang W; Zhao Z; Zhao R; Lv Z; Guo X; Gu Q; Liu B; Lv H; Chen J; Zhang K; Li F; Wang J
Adv Sci (Weinh); 2024 Apr; 11(14):e2306311. PubMed ID: 38298116
[TBL] [Abstract][Full Text] [Related]
11. A Novel Non-Psychoactive Fatty Acid from a Marine Snail,
Vijayaraghavan CS; Raman LS; Surenderan S; Kaur H; Chinambedu MD; Thyagarajan SP; Gnanambal Krishnan ME
Molecules; 2024 Apr; 29(8):. PubMed ID: 38675558
[TBL] [Abstract][Full Text] [Related]
12. Determination of rat leptin activity in vitro using a novel luciferase reporter assay.
Ju SK; Park JH; Na SY; You KH; Kim KL; Lee MK
Mol Cells; 2001 Aug; 12(1):131-6. PubMed ID: 11561723
[TBL] [Abstract][Full Text] [Related]
13. Cannabinoid Receptor Signaling is Dependent on Sub-Cellular Location.
Thomas A; Lobingier BT; Schultz C; Laguerre A
bioRxiv; 2024 Mar; ():. PubMed ID: 38562854
[TBL] [Abstract][Full Text] [Related]
14. CB1 Cannabinoid Receptor Signaling and Biased Signaling.
Leo LM; Abood ME
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500853
[TBL] [Abstract][Full Text] [Related]
15. Structure-Effect Relationships of Novel Semi-Synthetic Cannabinoid Derivatives.
Götz MR; Collado JA; Fernández-Ruiz J; Fiebich BL; García-Toscano L; Gómez-Cañas M; Koch O; Leha A; Muñoz E; Navarrete C; Pazos MR; Holzgrabe U
Front Pharmacol; 2019; 10():1284. PubMed ID: 31824305
[No Abstract] [Full Text] [Related]
16. New Insights in Cannabinoid Receptor Structure and Signaling.
Ye L; Cao Z; Wang W; Zhou N
Curr Mol Pharmacol; 2019; 12(3):239-248. PubMed ID: 30767756
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid CB
Ibsen MS; Connor M; Glass M
Cannabis Cannabinoid Res; 2017; 2(1):48-60. PubMed ID: 28861504
[TBL] [Abstract][Full Text] [Related]
18. Functional Selectivity of CB2 Cannabinoid Receptor Ligands at a Canonical and Noncanonical Pathway.
Dhopeshwarkar A; Mackie K
J Pharmacol Exp Ther; 2016 Aug; 358(2):342-51. PubMed ID: 27194477
[TBL] [Abstract][Full Text] [Related]
19. Non-Selective Cannabinoid Receptor Antagonists, Hinokiresinols Reduce Infiltration of Microglia/Macrophages into Ischemic Brain Lesions in Rat via Modulating 2-Arachidonolyglycerol-Induced Migration and Mitochondrial Activity.
Jalin AM; Rajasekaran M; Prather PL; Kwon JS; Gajulapati V; Choi Y; Kim C; Pahk K; Ju C; Kim WK
PLoS One; 2015; 10(10):e0141600. PubMed ID: 26517721
[TBL] [Abstract][Full Text] [Related]
20. Modulation of HIVGP120 Antigen-Specific Immune Responses In Vivo by Δ9-Tetrahydrocannabinol.
Chen W; Crawford RB; Kaplan BL; Kaminski NE
J Neuroimmune Pharmacol; 2015 Jun; 10(2):344-55. PubMed ID: 25900076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
